PharmAthene, Inc. (PIP) Reports Third Quarter 2013 Financial and Operational Results
11/8/2013 7:10:49 AM
ANNAPOLIS, Md., Nov. 7, 2013 /PRNewswire/ --
-- On track to commence SparVax(R) Phase 2 clinical trial
-- Presented new SparVax(R) anthrax vaccine data at the 2013 Bacillus-ACT
International Conference and the 53rd Annual Interscience Conference on
Antimicrobial Agents and Chemotherapy
Help employers find you! Check out all the jobs and post your resume.